Dermata Therapeutics Inc (DRMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 3,200 | 3,226 | 2,884 | 3,204 | 2,220 |
| Operating Income | -3,200 | -3,226 | -2,884 | -3,204 | -2,220 |
| Other Income | 49 | 53 | 55 | 69 | 86 |
| Pre-tax Income | -3,151 | -3,173 | -2,829 | -3,134 | -2,134 |
| Net Income Continuous | -3,151 | -3,173 | -2,829 | -3,134 | -2,134 |
| Net Income | $-3,151 | $-3,173 | $-2,829 | $-3,134 | $-2,134 |
| EPS Basic Total Ops | 52.51 | -20.41 | -41.82 | -70.60 | 115.63 |
| EPS Basic Continuous Ops | 52.50 | -20.41 | -41.82 | -70.59 | 116.03 |
| EPS Diluted Total Ops | 52.51 | -20.41 | -41.82 | -70.60 | 115.63 |
| EPS Diluted Continuous Ops | 52.50 | -20.41 | -41.82 | -70.59 | 116.03 |
| EPS Diluted Before Non-Recurring Items | N/A | -20.40 | -41.80 | -70.47 | N/A |
| EBITDA(a) | $-3,200 | $-3,226 | $-2,884 | $-3,204 | $-2,220 |